Life threatening emergencies from cancer complications or treatment that can occur anytime.
Obstructive Emergencies: Caused by tumor obstruction of organs or blood vessels.
Superior Vena Cava (SVC) Syndrome: Compression or obstruction leads to blood congestion.
Spinal Cord Compression (SCC): Tumor or bone degradation compresses the spinal cord.
Third Space Syndrome: Fluid shifts from vascular to interstitial spaces.
Intestinal Obstruction: Mechanical blockage due to tumors.
Metabolic Emergencies: Caused by ectopic hormone production or metabolic issues due to cancer.
Syndrome of Inappropriate Antidiuretic Hormone (SIADH): Excessive ADH leads to hyponatremia.
Hypercalcemia: High serum calcium levels.
Tumor Lysis Syndrome (TLS): Rapid cell destruction leads to electrolyte imbalances.
Sepsis: Severe infection in neutropenic patients.
Disseminated Intravascular Coagulation (DIC): Abnormal clotting and bleeding.
Infiltrative Emergencies: Cancer infiltrating major organs or due to treatment effects.
Cardiac Tamponade: Fluid accumulation around the heart.
Carotid Artery Rupture: Bleeding due to tumor invasion or treatment.
Mechanism: SVC returns blood from the head and upper body. Obstruction causes congestion.
Causes: Often in lymphoma, lung, and breast cancer; central venous catheter increases risk.
Manifestations: Facial edema, headaches, upper body erythema, dyspnea, cyanosis, hypotension.
Diagnosis: CT scan/MRI.
Interventions: Stent insertion, effective cancer treatment.
Overview: Neurological complications from tumors.
Signs: Back pain, numbness, tingling, possible paralysis.
Diagnosis: MRI.
Treatment: Corticosteroids, radiation, pain management, surgical intervention if necessary.
Definition: Fluid shift from vascular to interstitial spaces.
Causes: Immunotherapy, septic shock, extensive surgery.
Signs: Hypotension, tachycardia, decreased urine output.
Treatment: Fluid and electrolyte replacement.
Causes: Mechanical blockage from tumors affecting bowel motility, especially in GI-specific cancers.
Treatment Strategies: Palliative surgery vs. medical management; prioritize GI decompression.
Overview: Excess ADH secretion may be induced by certain cancers or treatments.
Symptoms: Weight gain, confusion, hyponatremia potentially leading to seizures.
Management: Fluid restriction, salt tablets, IV saline, diuretics, and treating underlying cancer.
Safety: Monitor for fluid overload signs (bounding pulse, crackles).
Epidemiology: Occurs in ~1/3 of cancer patients, especially those with bone involvement.
Symptoms: Fatigue, skeletal pain, renal issues, severe manifestations include muscle weakness.
Interventions: Hydration, diuretics, bisphosphonates, dialysis if life-threatening.
Description: Rapid destruction of tumor cells results in electrolyte imbalances: hyperkalemia, hyperuricemia.
Presentation: Can lead to cardiac issues and acute kidney injury.
Prevention/Treatment: Aggressive hydration, manage hyperkalemia, and monitor electrolytes post-treatment.
Nature: Severe infection in neutropenic patients due to impaired immune function.
Management: Immediate antibiotic therapy is crucial to prevent septic shock.
Cause: Often caused by sepsis, leads to extensive clotting and bleeding.
Symptoms: Bleeding from multiple sites, decreased blood flow to organs.
Management: Anticoagulants in early stages; clotting factors in later stages.
Definition: Accumulation of fluid in the pericardial sac due to tumor or radiation therapy.
Symptoms: Chest heaviness, dyspnea, tachycardia, anxiety.
Interventions: Pericardial window, catheter insertion, hydration, oxygen therapy.
Overview: Tumor invasion or erosion of arterial walls, primarily in head and neck cancers.
Symptoms: Oozing to complete hemorrhage.
Management: IV fluids, blood products, surgical ligation.